BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36065133)

  • 1. PLCE1 as a diagnostic and prognostic biomarker by promoting the growth and progression of oral squamous cell carcinoma.
    Abulaiti Z; Chen L; Xiao Q; Aimaier A; Ma Y; He S; Zhang J; Xu J; Cui X
    J Oral Pathol Med; 2022 Oct; 51(9):771-779. PubMed ID: 36065133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
    Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
    Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
    Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
    EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
    Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
    J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of XRN2 acts as an oncogene in oral squamous cell carcinoma and correlates with poor prognosis.
    Liu JC; Gao L; Li SM; Zheng JJ; Li DG; Zhi KQ; Ren WH
    Pathol Res Pract; 2021 Mar; 219():153355. PubMed ID: 33626405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance, prognostic value and biological role of lncRNA LINC01793 in oral squamous cell carcinoma.
    Yuan SJ; Li SY; Wang YH; Zhang HF; Hua Y; Wang T
    Arch Oral Biol; 2021 May; 125():105105. PubMed ID: 33713982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
    Liu Y; Li R; Ren G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients.
    Bigagli E; Locatello LG; Di Stadio A; Maggiore G; Valdarnini F; Bambi F; Gallo O; Luceri C
    J Oral Pathol Med; 2022 Apr; 51(4):350-357. PubMed ID: 34800057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoexpression of Tumor Infiltrating Lymphocytes(TILS) CD4 + and CD8 + in Oral Squamous Cell Carcinoma (OSCC) in Correlations with Clinicopathological Characteristics and Prognosis.
    Wahbi HS; Manadili A
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4177-4183. PubMed ID: 36580000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
    Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
    Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PLCE1 gene silencing by RNA interference on cell cycling and apoptosis in esophageal carcinoma cells.
    Zhao L; Wei ZB; Yang CQ; Chen JJ; Li D; Ji AF; Ma L
    Asian Pac J Cancer Prev; 2014; 15(13):5437-42. PubMed ID: 25041015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Synuclein-
    Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
    Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Zhang W; Gao C; Zhang S; Fang G
    J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01123 is associated with prognosis of oral squamous cell carcinoma and involved in tumor progression by sponging miR-34a-5p.
    Qin H; Wang C; Hua Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jan; 133(1):50-59. PubMed ID: 34511356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
    Jiang T; Liu G; Wang L; Liu H
    PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4.
    Yang J; Wang H; Xu W; Chen Z; Yan ZY; Zhang LJ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12717-12726. PubMed ID: 33378019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.